This inventor holds 1 USPTO granted patent and 6 published patent applications and 3 EPO patents. Top assignee: Amgen Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Nicholas Anthony Weires
Introduction
Nicholas Anthony Weires is an accomplished inventor based in Thousand Oaks, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific biological activities.
Latest Patents
Weires holds a patent for PRMT5 inhibitors, which are described as novel compounds that inhibit PRMT5 activity. These compounds may have therapeutic applications in treating proliferative, metabolic, and blood disorders. The patent outlines the structure of these compounds, which are represented by Formula I, along with their pharmaceutically acceptable salts and compositions.
Career Highlights
Weires is associated with Amgen Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Amgen has focused on creating effective treatments that address critical health issues.
Collaborations
Throughout his career, Weires has collaborated with notable colleagues, including Shon Booker and Matthew Paul Bourbeau. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Nicholas Anthony Weires is a prominent inventor whose work on PRMT5 inhibitors showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various disorders significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile